Supply Glut

Showing 866 articles
Business

DaVita Navigates Headwinds as Integrated Kidney Care Turns Profitable Ahead of Schedule

DaVita Inc. reported Q4 2025 results in line with expectations, highlighting a milestone first profitable year for its Integrated Kidney Care unit. While revenue per treatment accelerated, the company continues to face pressure from elevated patient mortality and rising benefit costs. Executives provided 2026 guidance projecting mid-single-digit operating income growth and a sharp rise in EPS, buoyed by share buybacks and the stabilization of prior investment losses.

Business

Palantir Shatters Records as U.S. AI Demand Fuels Historic Growth

Palantir Technologies' fourth-quarter earnings reveal a seismic shift, with U.S. commercial revenue for its AI Platform soaring 137%. The data analytics firm posted its highest growth rate as a public company, powered by massive government contracts and enterprise adoption, while setting aggressive targets for the year ahead.

Business

Brunswick's Strong Q4 and Aggressive Buybacks Fuel Investor Debate on Valuation

Brunswick Corporation (NYSE:BC) delivered robust fourth-quarter results, driven by strength across all segments, particularly its propulsion business. While management expressed optimism for 2026, the company's accelerated share repurchases have sparked a fresh debate among analysts regarding its valuation and the sustainability of its current momentum.